Notizie AIOM – anno XV
Ribociclib Recommended for EU Approval in Frontline HR+/HER2- Breast Cancer
June 23, 2017 - The Committee for Medicinal Products for Human Use (CHMP), a part of the European Medicines Agency (EMA), recommended approval of ribociclib for use in combination with an aromatase inhibitor as a first-line treatment for postmenopausal women with hormone ...Leggi tutto
Web-app
Una nuova web-app gratuita, in otto lingue, per computer, tablet e smartphone sul melanoma è disponibile sul sito del Corriere della Sera in collaborazione con l'Associazione Italiana di Oncologia Medica (leggi e scarica). Strumento interattivo in due versioni, per ...Leggi tutto
FDA approves Daratumumab in combination with Pomalidomide and Dexamethasone for relapsed ore refractory multiple Myelomale Myeloma
June 16, 2017 - The U.S. Food and Drug Administration (FDA) has approved the use of daratumumab in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior therapies including lenalidomide and ...Leggi tutto
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study
Clinicians and patients often overestimate the benefits of chemotherapy, and overall survival (OS), in platinum resistant/refractory ovarian cancer (PRROC). This study sought to determine aspects of health-related quality of life and clinicopathological characteristics before ...Leggi tutto
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
Symptoms are common among patients receiving treatment for advanced cancers, yet are undetected by clinicians up to half the time. There is growing interest in integrating electronic patient-reported outcomes (PROs) into routine oncology practice for symptom monitoring, ...Leggi tutto
The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population
Recently, tremendous prominence has been given to the investigation of the effect of different research processes as part of the Cancer Moonshot. More than half a century ago, the National Cancer Institute (NCI) established a network of publicly funded cancer cooperative ...Leggi tutto
Oncologist Barbara L. McAneny, MD, FASCO, MACP, Elected AMA President-Elect
June 13, 2017 - Physicians gathered at the Annual Meeting of the American Medical Association (AMA) elected Barbara McAneny, MD, FASCO, MACP, an oncologist from Albuquerque, New Mexico, as the new President-Elect of the physicians' organization. Following a year-long term ...Leggi tutto